The most expensive study is one you have to repeat. 10 things to know before you start your GLP study.

Good laboratory practice (GLP) studies are an essential component to medical product development and regulatory submissions. They are highly rigorous, are conducted in compliance with a  legally bound code of federal regulations (21 CFR Part 58) and should be conducted by qualified scientists and staff of an accredited contract research organization (CRO). They are also…

Selecting the right preclinical partner: Why Cell Constructs utilizes T3 Labs as their trusted Preclinical CRO

For medical product innovators large and small, T3 Labs prides itself on delivering the highest value preclinical testing and bioskills training services available. Depending on the class and type of submission, not every medical product requires preclinical studies, however, completing preclinical studies is advantageous for proof of concept, when raising capital, applying for reimbursement, and…

Improving patient outcomes through research and medtech innovation with confidence: Dr. Robert Matheny’s T3 narrative

Having a facility like T3 to test novel and breakthrough applications’ ability to save lives is crucial for battling diseases and disorders. Dr. Matheny and the original team of T3 recognized the need and saw to it that it was met. The change in landscape for innovators was born from desperation and a desire to…

Nerve Response Post Renal Denervation: Preclinical Testing Generates First Of Its Kind Documentation

Characterizing nerve response post renal denervation is the most critical aspect of any preclinical renal denervation study. Nerve atrophy, healing changes (fibrosis), condition of the perineurium, neuromatous regeneration; all of these aspects determine the success or failure of the denervation treatment. We are honored to present our most recent publication: “Neuromatous Regeneration as a Nerve…